Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 10,635,000 | 10,377,000 | 9,964,000 | 10,241,000 | 10,143,000 |
Cost of Goods | 4,698,000 | 4,603,000 | 4,463,000 | 4,556,000 | 4,605,000 |
Gross Profit | 5,937,000 | 5,774,000 | 5,501,000 | 5,685,000 | 5,538,000 |
Operating Expenses | 4,078,000 | 4,105,000 | 4,115,000 | 3,905,000 | 3,891,000 |
Operating Income | 1,859,000 | 1,669,000 | 1,386,000 | 1,780,000 | 1,647,000 |
Interest Expense | 51,000 | 140,000 | 141,000 | 159,000 | 166,000 |
Other Income | 132,000 | 78,000 | 191,000 | 174,000 | 190,000 |
Pre-tax Income | 1,940,000 | 1,607,000 | 1,436,000 | 1,795,000 | 1,671,000 |
Income Tax | 294,000 | 305,000 | 211,000 | 201,000 | 235,000 |
Net Income Continuous | 1,646,000 | 1,302,000 | 1,225,000 | 1,594,000 | 1,436,000 |
Net Income | $1,646,000 | $1,302,000 | $1,225,000 | $1,594,000 | $1,436,000 |
EPS Basic Total Ops | N/A | 0.74 | 0.70 | 0.92 | 0.82 |
EPS Basic Continuous Ops | N/A | 0.75 | 0.70 | 0.92 | 0.83 |
EPS Diluted Total Ops | 0.94 | 0.74 | 0.70 | 0.91 | 0.82 |
EPS Diluted Continuous Ops | 0.94 | 0.74 | 0.70 | 0.91 | 0.82 |
EPS Diluted Before Non-Recurring Items | N/A | 1.14 | 0.98 | 1.19 | 1.14 |
EBITDA(a) | $N/A | $2,474,000 | $2,191,000 | $2,593,000 | $2,471,000 |